Docket Room
SB 124·MD·senate

Food, Drugs, and Cosmetics - Gene Structure- and Function-Modifying Products - Labeling

WithdrawnFiled Oct 28, 2025
Sponsor: Benson
Latest Action

In the Senate - Unfavorable Report by Finance; Withdrawn

Feb 9, 2026

Summary

The bill would prohibit the sale of any product that modifies gene structure or function unless it is labeled prominently with the phrase “gene structure‑ or function‑modifying product” and a list of all reasonably possible risks. It targets manufacturers, distributors, and retailers of such biotech products, imposing criminal and civil penalties for violations. The measure received an unfavorable report in the Senate and was subsequently withdrawn.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when SB 124 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice